Quality-adjusted life expectancy (QALE) and loss of qale for patients with ischemic stroke and intracerebral hemorrhage: A 13-year follow-up

Stroke

Volumn 41, Issue 4, 2010, Pages 739-744

  Lee, Hsin Yi ^a   Hwang, Jing Shiang ^b   Jeng, Jiann Shing ^c   Wang, Jung Der ^c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Infarction; Intracerebral hemorrhage; Quality adjusted life years

Indexed keywords

ADULT; ARTICLE; BRAIN HEMORRHAGE; CEREBROVASCULAR ACCIDENT; COST EFFECTIVENESS ANALYSIS; EUROQOL 5 DIMENSION QUESTIONNAIRE; FEMALE; FOLLOW UP; HEALTH SURVEY; HUMAN; LIFE EXPECTANCY; MAJOR CLINICAL STUDY; MALE; MONTE CARLO METHOD; MORTALITY; PRIORITY JOURNAL; QUALITY ADJUSTED LIFE YEAR; STRUCTURED QUESTIONNAIRE; SURVIVAL; VITAL STATISTICS;

AGED; BRAIN INFARCTION; CEREBRAL HEMORRHAGE; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEALTH STATUS; HUMANS; KAPLAN-MEIERS ESTIMATE; LIFE EXPECTANCY; MALE; MIDDLE AGED; MONTE CARLO METHOD; QUALITY OF LIFE; QUALITY-ADJUSTED LIFE YEARS; QUESTIONNAIRES; REGISTRIES; REPRODUCIBILITY OF RESULTS; STROKE;

EID: 77950284282     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/STROKEAHA.109.573543     Document Type: Article

References (38)

1. Mechanic D, Rochefort DA. Comparative medical systems. Annu Rev Socio. 1996;22:239-270.
2. Porter ME. A strategy for health care reform\toward a value-based system. N Engl J Med. 2009;361:109-112.
3. Glasziou PP, Cole BF, Gelber RD, Hilden J, Simes RJ. Quality adjusted survival analysis with repeated quality of life measures. Stat Med. 1998; 17:1215-1229.
4. Hwang JS, Tsauo JY, Wang JD. Estimation of expected quality adjusted survival by cross-sectional survey. Stat Med. 1996;15:93-102.
5. Hwang JS, Wang JD. Monte Carlo estimation of extrapolation of quality-adjusted survival for follow-up studies. Stat Med. 1999;18:1627-1640.
6. Hwang JS, Wang JD. Integrating health profile with survival for quality of life assessment. Qual Life Res. 2004;13:1-14.
7. World Health Organization. Fact Sheet No. 310, 2004: The Top Ten Causes of Death. Geneva: World Health Organization; 2008.
8. Matchar DB, Samsa GP. Secondary and Tertiary Prevention of Stroke: Patient Outcomes Research Team (PORT) Final Report\Phase 1. Rockville, MD: Agency for Healthcare Research and Quality; 2000.
9. Lipscomb J, Ancukiewicz M, Parmigiani G, Hasselblad V, Samsa G, Matchar DB. Predicting the cost of illness: a comparison of alternative models applied to stroke. Med Decis Making. 1998;18:S39-S56.
10. Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, Chen RC, Yip PK. Subtypes and case-fatality rates of stroke: a hospital-based stroke registry in Taiwan (SCAN-IV). J Neurol Sci. 1998;156:220-226.
11. Yip PK, Jeng JS, Lee TK, Chang YC, Huang ZS, Ng SK, Chen RC. Subtypes of ischemic stroke: a hospital-based stroke registry in Taiwan (SCAN-IV). Stroke. 1997;28:2507-2512.
12. Adams HP, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon DL, Marsh EE. Classification of subtype of acute ischemic stroke. Definitions for use in a multicenter clinical trial. TOAST. Trial of Org 10172 in Acute Stroke Treatment. Stroke. 1993;24:35-41.
13. Fang CT, Chang YY, Hsu HM, Twu SJ, Chen KT, Lin CC, Huang LY, Chen MY, Hwang JS, Wang JD, Chuang CY. Life expectancy of patients with newly-diagnosed HIV infection in the era of highly active antiret-roviral therapy. QJM. 2007;100:97-105.
14. Ho JJ, Hwang JS, Wang JD. Estimation of reduced life expectancy from serious occupational injuries in Taiwan. Accid Anal Prev. 2006;38: 961-968.
15. Chu PC, Wang JD, Hwang JS, Chang YY. Estimation of life expectancy and the expected years of life lost in patients with major cancers: extrapolation of survival curves under high-censored rates. Value Health. 2008; 11:1102-1109.
16. Lee HY, Chen YH, Chiu WT, Hwang JS, Wang JD. Quality-adjusted life-years and helmet use among motorcyclist sustaining head injury. Am J Public Health. 2010;100:165-170.
17. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy. 1990;16:199-208.
18. Shaw JW, Johnson JA, Coons SJ. US valuation of the EQ-5D health states: development and testing of the D1 valuation model. Med Care. 2005;43:203-220.
19. Dolan P. Modeling valuations for EuroQol health states. Med Care. 1997;35:1095-1108.
20. Lawes CM, Vander Hoorn S, Rodgers A. Global burden of blood-pressure-related disease, 2001. Lancet. 2008;371:1513-1518.
21. Muennig PA, Gold MR. Using the years-of-healthy-life measure to calculate QALYs. Am J Prev Med. 2001;20:35-39.
22. Bronnum-Hansen H, Davidsen M, Thorvaldsen P. Long-term survival and causes of death after stroke. Stroke. 2001;32:2131-2136.
23. Hankey GJ, Jamrozik K, Broadhurst RJ, Forbes S, Burvill PW, Anderson CS, Stewart-Wynne EG. Five-year survival after first-ever stroke and related prognostic factors in the Perth Community Stroke Study. Stroke. 2000;31:2080-2086.
24. Grootendorst P, Feeny D, Furlong W. Health Utilities Index Mark 3: evidence of construct validity for stroke and arthritis in a population health survey. Med Care. 2000;38:290-299.
25. Mathias SD, Bates MM, Pasta DJ, Cisternas MG, Feeny D, Patrick DL. Use of the Health Utilities Index with stroke patients and their caregivers. Stroke. 1997;28:1888-1894.
26. Pickard AS, Johnson JA, Feeny DH, Shuaib A, Carriere KC, Nasser AM. Agreement between patient and proxy assessments of health-related quality of life after stroke using the EQ-5D and Health Utilities Index. Stroke. 2004;35:607-612.
27. Haacke C, Althaus A, Spottke A, Siebert U, Back T, Dodel R. Long-term outcome after stroke evaluating health-related quality of life using utility measurements. Stroke. 2006;37:193-198.
28. Fryback DG, Dunham NC, Palta M. US norms for six generic health-related quality-of-life indexes from the National Health Measurement Study. Med Care. 2007;45:1162-1170.
29. Luo N, Johnson JA, Shaw JW, Feeny D, Coons SJ. Self-reported health status of the general adult US population as assessed by the EQ-5D and Health Utilities Index. Med Care. 2005;43:1078-1086.
30. Orpana HM, Ross N, Feeny D, McFarland B, Bernier J, Kaplan M. The natural history of health-related quality of life: a 10-year cohort study. Health Reports. 2009;20:1-7.
31. Feeny D, Furlong W, Boyle M, Torrance GW. Multi-attribute health status classification systems. Health Utilities Index. Pharmacoeconomics. 1995;7:490-502.
32. Hsu C, Wang JD, Hwang JS. Survival-weighted health profile for long-term survivors of acute myelogenous leukemia. Qual Life Res. 2003;12:503-517.
33. Wolf SL, Winstein CJ, Miller JP. Retention of upper limb function in stroke survivors who have received constraint-induced movement therapy: the EXCITE randomised trial. Lancet Neurol. 2007;7:33-40.
34. Kubo M, Kiyohara Y, Kato I. Trends in the incidence, mortality, and survival rate of cardiovascular disease in a Japanese community: the Hisayama study. Stroke. 2003;34:2349-2354.
35. Norrving B. Long-term prognosis after lacunar infarction. Lancet Neurol. 2003;2:238-245.
36. Jorgensen HS, Nakayama H, Raaschou HO, Olsen TS. Intracerebral hemorrhage versus infarction: stroke severity, risk factors, and prognosis. Ann Neurol. 1995;38:45-50.
37. Jackson C, Sudlow C. Comparing risks of death and recurrent vascular events between lacunar and non-lacunar infarction. Brain. 2005;128: 2507-2517.
38. World Health Organization. Integrated Management of Cardiovascular Risk: Report of a WHO Meeting. Geneva: World Health Organization; 2002.